Upgrades Sec Perform Outperform X

RMD ResMed

RBC Capital Mkts

$294

Downgrades Outperform Sec Perform X

RMD ResMed

RBC Capital Mkts

$273 $202

Upgrades Sec Perform Outperform X

RMD ResMed

RBC Capital Mkts

$262 $284

Downgrades Outperform Sec Perform X

RMD ResMed

RBC Capital Mkts

$246 $252

Upgrades Sec Perform Outperform X

RMD ResMed

RBC Capital Mkts

$233 $244

Initiated Underperform X

RMD ResMed

RBC Capital Mkts

$223

RMD  ResMed Inc.

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.